The investigational therapy dazodalibep markedly eased disease activity in people with Sjögren’s syndrome with moderate-to-high systemic disease activity, meeting…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
A non-invasive imaging technique called in vivo confocal microscopy, or IVCM for short, was found to detect changes in the…
Alterations to immune dendritic cells in the eyes of people with Sjögren’s syndrome were associated with both bodywide and…
Mesenchymal stem cells (MSCs) isolated from dental tissue eased the signs and symptoms of Sjögren’s syndrome in a mouse…
Levels of antibodies that target the nuclear protein HMGB1 are elevated in the bloodstream of adults with Sjögren’s syndrome,…
The thickness of the eye’s retina and the density of retinal blood vessels are significantly lower in women with…
The experimental oral therapy cenerimod prevented immune cells from entering the salivary glands and reduced gland inflammation in two…
Immune macrophages — immune cells that fight infection — can mount distinct responses to specific pathogens, based on how a…
Infections with the Epstein-Barr virus (EBV), the most common member of the herpes virus family, may contribute to…
Production of Myd88, a protein associated with autoimmune diseases, in distinct types of cells mediates different characteristics of…